A dose of tranexamic acid to start and end noncardiac surgery reduced important bleeding events, the POISE-3 trial showed, albeit with a question mark hanging over cardiovascular risk.
CU Anschutz
Academic Office One
12631 East 17th Avenue
Room: 6111
Aurora, CO 80045